Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae

被引：42

作者：

Hansen, GT

Metzler, K

Drlica, K

Blondeau, JM ^{[1
]}

机构：

[1] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada

[2] Publ Hlth Res Inst, Newark, NJ 07193 USA

[3] Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK S7N 0W8, Canada

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 01期

关键词：

D O I：

10.1128/AAC.47.1.440-441.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：440 / 441

页数：2

共 16 条

[1] COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE [J].

BLASER, J ;

STONE, BB ;

GRONER, MC ;

ZINNER, SH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1054-1060

[2] Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae [J].

Blondeau, JM ;

Zhao, XL ;

Hansen, G ;

Drlica, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :433-438

[3]

BLONDEAU JM, 2001, 7 INT S NEW QUIN ED

[4] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].

Chen, DK ;

McGeer, A ;

de Azavedo, JC ;

Low, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239

[5] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].

Craig, WA .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10

[6] PHARMACODYNAMICS OF A FLUOROQUINOLONE ANTIMICROBIAL AGENT IN A NEUTROPENIC RAT MODEL OF PSEUDOMONAS SEPSIS [J].

DRUSANO, GL ;

JOHNSON, DE ;

ROSEN, M ;

STANDIFORD, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :483-490

[7] Increasing resistance of Streptococcus pneumoniae to fluoroquinolones:: results of a Hong Kong multicentre study in 2000 [J].

Ho, PL ;

Yung, RWH ;

Tsang, DNC ;

Que, TL ;

Ho, M ;

Seto, WH ;

Ng, TK ;

Yam, WC ;

Ng, WWS .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) :659-665

[8] Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries [J].

Nagai, K ;

Appelbaum, PC ;

Davies, TA ;

Kelly, LM ;

Hoellman, DB ;

Tambic Andrasevic, A ;

Drukalska, L ;

Hryniewicz, W ;

Jacobs, MR ;

Kolman, J ;

Miciuleviciene, J ;

Pana, M ;

Setchanova, L ;

Thege, MK ;

Hupkova, H ;

Trupl, J ;

Urbaskova, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :371-377

[9] Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae [J].

Nagai, K ;

Davies, TA ;

Dewasse, BE ;

Jacobs, MR ;

Appelbaum, PC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (03) :365-374

[10] Streptococcus pneumoniae, Brooklyn, New York:: Fluoroquinolone resistance at our doorstep [J].

Quale, J ;

Landman, D ;

Ravishankar, J ;

Flores, C ;

Bratu, S .

EMERGING INFECTIOUS DISEASES, 2002, 8 (06) :594-597

← 1 2 →